01 6Mepsevii
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2019 Revenue in Millions : 13
2018 Revenue in Millions : 8
Growth (%) : 60
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2020 Revenue in Millions : 15
2019 Revenue in Millions : 13
Growth (%) : 21
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2021 Revenue in Millions : 16
2020 Revenue in Millions : 15
Growth (%) : 5
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 21
2021 Revenue in Millions : 16
Growth (%) : 29
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 30
2022 Revenue in Millions : 21
Growth (%) : 48
Main Therapeutic Indication : Rare Diseases and Disorders
Currency : USD
2024 Revenue in Millions : 30
2023 Revenue in Millions : 30
Growth (%) : 0
